Silicon Laboratories financials
$221.17+0.06%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jul 4 | Q1 '26 Apr 4 | Q4 '25 Jan 3 | Q3 '25 Oct 4 | Q2 '25 Jul 5 | Q1 '25 Apr 5 | Q4 '24 Dec 28 | Q3 '24 Sep 28 | Q2 '24 Jun 29 | Q1 '24 Mar 30 | Q4 '23 Dec 30 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228.2M | $213.5M | $208.2M | $206.0M | $192.8M | $177.7M | $166.2M | $166.4M | $145.4M | $106.4M | $86.8M | $203.8M |
| Gross profit | $140.7M | $127.0M | $132.1M | $119.0M | $108.1M | $97.8M | $90.2M | $90.3M | $76.6M | $55.1M | $43.9M | $119.0M |
| Gross margin | 61.6% | 59.5% | 63.4% | 57.8% | 56.1% | 55.0% | 54.3% | 54.3% | 52.7% | 51.8% | 50.6% | 58.4% |
| Operating income | -$10.7M | -$17.1M | -$3.3M | -$12.3M | -$22.9M | -$32.1M | -$28.6M | -$29.7M | -$48.0M | -$59.1M | -$73.1M | $12.2M |
| Net income | -$10.6M | -$15.9M | -$2.7M | -$9.9M | -$21.8M | -$30.5M | -$23.8M | -$28.5M | -$82.2M | -$56.5M | -$69.8M | $10.3M |
| Net margin | −4.6% | −7.4% | −1.3% | −4.8% | −11.3% | −17.1% | −14.3% | −17.1% | −56.5% | −53.1% | −80.4% | 5.1% |
| Diluted EPS | $-0.32 | $-0.48 | $-0.08 | $-0.30 | $-0.67 | $-0.94 | $-0.73 | $-0.88 | $-2.56 | $-1.77 | $-2.45 | $0.32 |
| EBITDA | -$2.2M | -$8.7M | $5.0M | -$4.0M | -$13.1M | -$20.4M | -$16.9M | -$18.1M | -$35.4M | -$46.4M | -$73.1M | $25.0M |
| Operating cash flow | -$14.5M | $4.9M | $8.3M | $34.3M | $4.9M | $48.1M | $10.1M | $31.6M | $16.1M | -$71.8M | $18.5M | -$33.4M |
| Free cash flow | -$26.8M | -$4.9M | -$5.6M | $27.9M | -$3.8M | $43.3M | $6.2M | $29.4M | $12.6M | -$73.8M | $14.7M | -$38.6M |
| Diluted shares | 33.2M | 33.0M | 32.9M | 32.8M | 32.7M | 32.5M | 32.4M | 32.3M | 32.1M | 31.9M | 28.5M | 32.1M |
Balance sheet
| Period end | Jul 4 | Apr 4 | Jan 3 | Oct 4 | Jul 5 | Apr 5 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $362.2M | $383.1M | $364.2M | $341.4M | $314.5M | $324.9M |
| Short-term investments | $35.1M | $55.8M | $79.4M | $97.6M | $101.1M | $99.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.25B | $1.27B | $1.27B | $1.25B | $1.22B | $1.23B |
| Total liabilities | $158.3M | $167.9M | $174.9M | $182.4M | $160.0M | $161.1M |
| Shareholders' equity | $1.09B | $1.10B | $1.09B | $1.07B | $1.06B | $1.07B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology